Rand Bioscience Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $2.62M

  • Investors
  • 8

Rand Bioscience General Information

Description

Developer of drugs designed to make mankind free and happy from disease. The company discovers and evaluates innovative new drugs and global licensing for cancer and immunology therapies, enabling healthcare companies to find new ways to cure various diseases and help patients live healthy lives.

Contact Information

Website
www.randbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 402, 403. 4th floor, 82 Daehak-ro
  • Yuseong-gu, Daejeon- A108
  • Daejeon
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 402, 403. 4th floor, 82 Daehak-ro
  • Yuseong-gu, Daejeon- A108
  • Daejeon
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rand Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series B) 02-Aug-2021 $2.62M Completed Clinical Trials - Phase 1
2. Early Stage VC (Series A) 09-May-2019 Completed Clinical Trials - Phase 1
1. Seed Round 04-Jan-2016 Completed Startup
To view Rand Bioscience’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Rand Bioscience Patents

Rand Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2014277262-A1 A quinoline inhibitor of the macrophage stimulating 1 receptor mst1 r Active 06-Jun-2013
AU-2014277262-B2 A quinoline inhibitor of the macrophage stimulating 1 receptor mst1 r Inactive 06-Jun-2013
CA-2914500-A1 A quinoline inhibitor of the macrophage stimulating 1 receptor mst1 r Active 06-Jun-2013
CA-2914500-C A quinoline inhibitor of the macrophage stimulating 1 receptor mst1 r Active 06-Jun-2013 C07D401/14

Rand Bioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rand Bioscience Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ontide Corporation Minority
Shinhan Venture Investment Venture Capital Minority
C&R Research Corporation Minority
Emford Equity Partners Venture Capital Minority
KB Investment Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Rand Bioscience FAQs

  • When was Rand Bioscience founded?

    Rand Bioscience was founded in 2015.

  • Where is Rand Bioscience headquartered?

    Rand Bioscience is headquartered in Daejeon, South Korea.

  • What is the size of Rand Bioscience?

    Rand Bioscience has 6 total employees.

  • What industry is Rand Bioscience in?

    Rand Bioscience’s primary industry is Drug Discovery.

  • Is Rand Bioscience a private or public company?

    Rand Bioscience is a Private company.

  • What is Rand Bioscience’s current revenue?

    The current revenue for Rand Bioscience is .

  • How much funding has Rand Bioscience raised over time?

    Rand Bioscience has raised $13.2M.

  • Who are Rand Bioscience’s investors?

    Ontide, Shinhan Venture Investment, C&R Research, Emford Equity Partners, and KB Investment are 5 of 8 investors who have invested in Rand Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process